What to know about Zuranolone, the first FDA-approved pill for postpartum depression

Postpartum depression has long been overlooked. Zurzuvae (Zuranolone), a new oral treatment, expands potential treatment options.

Related Keywords

Tiffany Farchione ,Samantha Meltzer Brody ,Cnn ,Drug Administration ,University Of North Carolina At Chapel Hill ,American College Of Obstetricians ,Columbia University ,Drug Evaluation ,American College ,Sage Therapeutics ,Mood Disorders ,North Carolina ,Chapel Hill ,